These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6792047)

  • 1. Infection in the compromised host.
    Young LS
    Hosp Pract (Off Ed); 1981 Sep; 16(9):73-84. PubMed ID: 6792047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunodeficiency and infection].
    Hess C
    Ther Umsch; 2014 Jan; 71(1):3. PubMed ID: 24394203
    [No Abstract]   [Full Text] [Related]  

  • 3. [The mechanisms of immunologic tissue lesions].
    Ahlqvist J; Wager O
    Duodecim; 1973; 89(2):84-96. PubMed ID: 4685139
    [No Abstract]   [Full Text] [Related]  

  • 4. [The characteristics of infectious immunosuppression in patients with benign subleukemic myelosis].
    Guseva SA
    Lik Sprava; 1995; (7-8):32-6. PubMed ID: 8846368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic infection in children. II. In the compromised host.
    Feigin RD; Shearer WT
    J Pediatr; 1975 Nov; 87(5):677-94. PubMed ID: 1102640
    [No Abstract]   [Full Text] [Related]  

  • 6. Necroptotic death signaling: evolution, mechanisms and disease relevance.
    Vince JE
    Immunol Cell Biol; 2017 Feb; 95(2):129-130. PubMed ID: 28194028
    [No Abstract]   [Full Text] [Related]  

  • 7. Infection in the immunocompromised host.
    Leyden JJ
    Arch Dermatol; 1985 Jul; 121(7):855-7. PubMed ID: 3893324
    [No Abstract]   [Full Text] [Related]  

  • 8. The immune compromised host.
    Hughes WT; Tufenkeji H; Bartley DL
    Pediatr Clin North Am; 1983 Feb; 30(1):103-20. PubMed ID: 6338459
    [No Abstract]   [Full Text] [Related]  

  • 9. Complications of the myeloproliferative system: infection and sepsis.
    Ellerhorst-Ryan JM
    Semin Oncol Nurs; 1985 Nov; 1(4):244-50. PubMed ID: 3854235
    [No Abstract]   [Full Text] [Related]  

  • 10. Current understanding of fever and host immunity.
    Alqahtani M; Mukundan D
    Curr Opin Pediatr; 2011 Feb; 23(1):115-20. PubMed ID: 21191298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasuppression, class I antigens, and cancer immunity.
    Green DR; Gershon RK
    Haematol Blood Transfus; 1983; 28():479-85. PubMed ID: 6602750
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of cellular and humoral factors in infections.
    Neu HC
    Clin Haematol; 1976 Jun; 5(2):449-65. PubMed ID: 780033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
    Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
    Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolution of innate immune sensors and responses during immune disorders and immunization against microbial infection.
    Kumar H
    Int Rev Immunol; 2018; 37(5):215-216. PubMed ID: 30418071
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacterial complications of transplantation: diagnosis and treatment.
    Donnelly JP
    J Antimicrob Chemother; 1995 Oct; 36 Suppl B():59-72. PubMed ID: 8601544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer factor in tropical disease.
    Gatenby P
    P N G Med J; 1978 Mar; 21(1):65-8. PubMed ID: 286485
    [No Abstract]   [Full Text] [Related]  

  • 17. Epigenetic regulation of the immune system in health and disease.
    Fernández-Morera JL; Calvanese V; Rodríguez-Rodero S; Menéndez-Torre E; Fraga MF
    Tissue Antigens; 2010 Dec; 76(6):431-9. PubMed ID: 21058938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.
    Byun S; Lee E; Lee KW
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological principles and their clinical application].
    Romero Herrera M; Miranda Feria AJ; Guillén Toledo J; Vilchis Mendoza M
    Alergia; 1977 Oct; 24(4):173-86. PubMed ID: 305209
    [No Abstract]   [Full Text] [Related]  

  • 20. [The 1980's: anti-idiotypical reagins as a selective weapon against unwanted immunoreactivity].
    Holm G
    Lakartidningen; 1979 Dec; 76(52):4789-91. PubMed ID: 545004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.